208 related articles for article (PubMed ID: 10540369)
1. Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives.
Vamvakas EC
J Clin Apher; 1999; 14(3):135-43. PubMed ID: 10540369
[TBL] [Abstract][Full Text] [Related]
2. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.
Crowder LA; Dodd RY; Schonberger LB
Transfusion; 2024 Jun; 64(6):980-985. PubMed ID: 38650381
[TBL] [Abstract][Full Text] [Related]
3. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
Crowder LA; Schonberger LB; Dodd RY; Steele WR
Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
[TBL] [Abstract][Full Text] [Related]
4. Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
Menache D; O'Malley JP
Biologicals; 1996 Sep; 24(3):277-83. PubMed ID: 8978926
[TBL] [Abstract][Full Text] [Related]
5. Variant Creutzfeldt-Jakob disease.
Ironside JW
Haemophilia; 2010 Jul; 16 Suppl 5():175-80. PubMed ID: 20590878
[TBL] [Abstract][Full Text] [Related]
6. The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.
Hoots WK; Abrams C; Tankersleydagger D
Transfus Med Rev; 2001 Apr; 15(2 Suppl 1):45-59. PubMed ID: 11441420
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease and blood transfusion.
Esmonde TF; Will RG; Slattery JM; Knight R; Harries-Jones R; de Silva R; Matthews WB
Lancet; 1993 Jan; 341(8839):205-7. PubMed ID: 8093499
[TBL] [Abstract][Full Text] [Related]
9. No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.
Holmqvist J; Wikman A; Pedersen OBV; Nielsen KR; Rostgaard K; Hjalgrim H; Edgren G
Transfusion; 2020 Apr; 60(4):694-697. PubMed ID: 32187687
[TBL] [Abstract][Full Text] [Related]
10. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
Hamaguchi T; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Yamada M
Neuropathology; 2009 Oct; 29(5):625-31. PubMed ID: 19659942
[TBL] [Abstract][Full Text] [Related]
11. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
Ludlam CA; Turner ML
Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
[TBL] [Abstract][Full Text] [Related]
12. Risk of variant Creuzfeldt-Jakob disease from factor concentrates: current perspectives.
Farrugia A
Haemophilia; 2002 May; 8(3):230-5. PubMed ID: 12010416
[TBL] [Abstract][Full Text] [Related]
13. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion.
Turner ML; Ironside JW
Blood Rev; 1998 Dec; 12(4):255-68. PubMed ID: 9950096
[TBL] [Abstract][Full Text] [Related]
14. Creutzfeldt-Jakob disease and the risk from blood or blood products.
Will RG; Kimberlin RH
Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
[TBL] [Abstract][Full Text] [Related]
15. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
[TBL] [Abstract][Full Text] [Related]
16. Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK.
Hall V; Brookes D; Nacul L; Gill ON; Connor N;
J Hosp Infect; 2014 Sep; 88(1):22-7. PubMed ID: 25082752
[TBL] [Abstract][Full Text] [Related]
17. Development of dose-response models of Creutzfeldt-Jakob disease infection in nonhuman primates for assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
Huang Y; Gregori L; Anderson SA; Asher DM; Yang H
J Virol; 2014 Dec; 88(23):13732-6. PubMed ID: 25231313
[TBL] [Abstract][Full Text] [Related]
18. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
[TBL] [Abstract][Full Text] [Related]
19. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
Turner ML; Ludlam CA
Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
[TBL] [Abstract][Full Text] [Related]
20. Variant CJD and blood transfusion: are there additional cases?
Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
